Pressotherapy Systems Market Share

North America Market Insights

North America market is anticipated to be the dominant region, with the highest share of 38.1% by the end of 2035. The market’s growth in the region is effectively fueled by an increase in chronic disease prevalence, an expansion in sports medicine, the demand for post-surgical rehabilitation, strong reimbursement support, and technological advancements. As per the October 2024 CDC report, 6 in 10 people in the region are affected by one chronic disease, and 4 out of 10 suffer from 2 chronic conditions. Additionally, diabetes, cancer, and heart disease are driving USD 4.9 trillion healthcare expenses in the U.S., thus suitable for the market’s development.

The pressotherapy systems market in the U.S. is gaining increased traction, owing to a surge in sports medicine demand and import and export facilities for valves. In this regard, the University of Western States, in its February 2025 article, stated that an estimated 30 million children in the country play sports, leading to an average of 3.5 million injuries every year during adolescence. Additionally, there has been an increase in students participating at the National Collegiate Athletic Association (NCAA) level by more than 3,000 athletes. Besides, as per the July 2025 OEC report, the country is the top exporter and importer of valves, with a valuation of USD 522 million and USD 559 million, as of 2023, thus catering to the market’s growth.

 The pressotherapy systems market in Canada is also steadily growing due to the occurrence of non-communicable diseases and the provision of government funds and strategies. For instance, the October 2024 Pan American Health Organization data report stated that the tobacco prevalence in the country among more than 15 years of age was 12.0%, for which pressotherapy systems are implemented as a supportive therapy. Meanwhile, the May 2022 Government of Canada report noted that over 750,000 people are affected by heart failure, with approximately 100,000 new cases every year. To reduce this, the government made a provision of USD 5 million to develop a national research network to augment the prevention procedure.

Public Expenditure on Health in North America (2024)

Source: Pan American Health Organization, October 2024

APAC Market Insights

Asia Pacific market is projected to be the fastest-growing region, accounting for a share of 22.3% during the forecast period. The market’s upliftment in the region is attributed to an increase in venous diseases, a surge in medical tourism to ensure cost-effective therapies, an upsurge in the fitness industry, and expansion in private healthcare facilities. As per the August 2022 NLM article, the varicose vein disease, which is a type of venous disorder, prevalence rate is 18%, which is less in comparison to other nations. Additionally, the incidence rate in Japan was 45%, and 8.3% in China, thus denoting a huge demand for the market. Besides the October 2024, the Lancet Global Health article denoted that majority of the population spends 10% of yearly consumption expenditure on healthcare, which is also driving the market.

The pressotherapy systems market in China is gaining increased exposure, owing to modernization in government-supported healthcare services, the presence of regional MedTech manufacturing, and an increase in the aging population. As stated in the July 2023 NLM article, in 2022, Shanghai United Imaging Medical Technology Co., Ltd., successfully collaborated with Zhongshan Hospital to introduce the Time-of-Flight Intracranial MRA. This ensured scientific research and technological (Sci-tech) and digital health innovation in the medical field, particularly across different hospitals. Besides, 25% of hospitals in the country have better innovation performance, which is readily driving the market’s demand.

The pressotherapy systems market in India is also growing due to the presence of Ayushman Bharat coverage, an increase in the demand for portable devices, and the availability of equipment sourcing to check and measure pressure. According to the October 2024 India Government report, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) provided free health insurance coverage of Rs 5 lakh (USD 5,706) per family for senior citizens and ensured accessibility to the scheme’s benefits. Meanwhile, the 2023 OEC data report indicated that the country is the top importer of equipment, with a valuation of USD 179 million in 2023, with an ECI ranking of 39 out of 132, thus suitable for the market’s growth.

Lymphatic Fibrosis Incidence in Asia (2021)

Source: NLM, January 2021

Europe Market Insights

Europe in the pressotherapy systems market is expected to garner a considerable share of 28.4% by the end of the projected timeline. The market’s growth in the region is propelled by a surge in aging demographics, advancement in health and medical services, sports medicine availability, and growth in medical tourists. As stated in the December 2023 NLM report, over 1/5^th of the population in Europe Union is aged more than 60 years, along with a ratio of 3 working-age people. In addition, elderly people are expected to constitute almost 1/3^rd of the population by the end of 2050. This denotes a rise in chronic diseases, which in turn, enhances the demand for the market in the overall region.

The pressotherapy systems market in Germany is rapidly growing since there exists the provision of a healthcare budget, a robust MedTech sector, as well as reimbursement policies. According to a data report published by the ITA in August 2025, the country imported an estimated USD 3.1 billion of medical appliances and instruments from the U.S. This, in turn, led to an almost 2.0% of the international total for this category, which denotes a huge development for the market. Likewise, there has been a generous import of medical and technical apparatus to the country of worth USD 9.8 billion, thereby suitable for the market’s upliftment.

The pressotherapy systems market in the UK is significantly growing due to the existence of the NHS investment, extension in home care services, and post-Brexit policies. As per the June 2025 Government UK report, the provision of £6 billion investment ensured latest scanners, diagnostic capacities, emergency treatment centers, and ambulances. In addition, 92% of patients commenced with consult-based treatments within 18 weeks, and the 4 million additional tests, procedures, and scans are also available to them. Besides, there has been another investment of £30 billion for five years regarding the repairment and maintenance of the NHS estate, to ensure continuous funding provision, which creates a positive outlook for the market in the country.